Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria treatment monitoring in Central Vietnam
ACTRN12621001085864Phase 4Recruiting
- Sponsor
- Australian Defence Force Malaria and Infectious Disease Institute
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pyronaridine, primaquine and chloroquine in malaria, Falciparum malaria (PF) and vivax malaria, sponsored by Australian Defence Force Malaria and Infectious Disease Institute. Primary endpoints: Parasite clearance time, Fever clearance time and 1 more. Started Jun 2022; status: recruiting.
02
Drugs
pyronaridineprimaquinechloroquine
03
Conditions
malariaFalciparum malaria (PF)vivax malaria
Beyond the preview
Go deeper on ACTRN12621001085864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001085864.